Post by
up2005 on Jan 11, 2022 12:45am
This has been an extremely painful investment.
The LTC bed count has risen, Good, the dispensing fee mandated by various provincial governments has been decreased. The move to using less profitable generic drugs has hurt our bottom line. The investment in the Kerie pill dispensing devices was a MASSIVE mistake. They can't seem to get past this $ 5.00. We are back to where we were last February. It looks positive during the summer months $ 6.20 - $ 6.80.
Comment by
Crazygirl123 on Jan 11, 2022 5:30pm
plus high turnover rate of employees. Pay so much money for overtime, especially pharmacists, unused inventory or expired drugs etc...Over 95 percent is generic drug
Comment by
MrMugsy on Jan 11, 2022 10:47pm
Record revenues, record bed count, climbing EBITDA and positive cashflow of $12M for the last quarter. What's not to like right now ?
Comment by
SR71BlackBird on Jan 12, 2022 12:45am
I think the real problem here is that somebody, like an Amazon, is going to come by and jump into this industry. I think it's right for material disruption. IMO